Clinical Trial Update: Vildagliptin in New Onset Diabetes After Transplantation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating vildagliptin for new onset diabetes after transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Vildagliptin (vildagliptin)

Snippet

Sponsor: Medical University of Vienna | Conditions: Diabetes Mellitus | Phase 2 | Status: COMPLETED